RWE and HTA: a snapshot of recent developments with Sreeram Ramagopalan – August–September 2021

2 Nov 2021

Written by Sreeram Ramagopalan (F. Hoffmann-La Roche)

Decision science Guest columns Health technology assessment Industry Updates Journal articles Methodology Real-world evidence

Read highlights from the latest instalment of Sreeram Ramagopalan’s (F. Hoffmann-La Roche, Basel, Switzerland) industry news round-up, which discusses some of the latest developments in real-world evidence (RWE) in the context of health technology assessment (HTA) and is published bi-monthly in our partner journal, the Journal of Comparative Effectiveness Research. Read the full update for August–September 2021 in the Journal of Comparative Effectiveness Research here >>> What happened over these months that you were expecting? Given how frequently RWE is discussed I was expecting updated guidelines from HTA agencies on how they will consider RWE to understand treatment effectiveness, as...